<p>DAVENPORT &amp; Co LLC 在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在 HealthEquity, Inc.（NASDAQ:HQY - 免费报告）中的持股比例提高了 23.9%。该公司在季度内额外收购了 74,431 股后，持有该公司 386,388 股股票。DAVENPORT &amp; Co LLC 在最近的报告期末持有约 0.45% 的 HealthEquity，价值 36,773,000 美元。</p>
<ul>
<li>选举后罗素 2000 指数飙升：如何把握小盘股的机会</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也增加或减少了在 HQY 的持股。Price T Rowe Associates Inc. MD 在第一季度将其在 HealthEquity 的持股比例提高了 995.6%。Price T Rowe Associates Inc. MD 目前持有 639,345 股该公司股票，价值 56,500,000 美元，此前在上个季度又购买了 580,988 股。Westfield Capital Management Co. LP 在第二季度将其在 HealthEquity 的持股提高了 124.6%。Westfield Capital Management Co. LP 目前持有 1,265,208 股该公司股票，价值 132,543,000 美元，此前在上个季度又收购了 701,819 股。Banco Bilbao Vizcaya Argentaria S.A. 在第二季度购买了 HealthEquity 的新头寸，价值约 492,000 美元。Artisan Partners Limited Partnership 在第二季度将其在 HealthEquity 的持股提高了 44.8%。Artisan Partners Limited Partnership 目前持有 621,647 股该公司股票，价值 65,124,000 美元，此前在上个季度又购买了 192,252 股。最后，Ashford Capital Management Inc. 在第一季度将其在 HealthEquity 的持股提高了 2.1%。Ashford Capital Management Inc. 目前持有 274,999 股该公司股票，价值 24,302,000 美元，此前在上个季度又购买了 5,687 股。机构投资者目前持有该公司 99.55% 的股票。</p>
<h2>内部人士下注</h2>
<p>在其他消息中，执行副总裁 Elimelech Rosner 于 12 月 18 日星期四出售了 10,959 股该股票。股票以平均价格 95.45 美元出售，总价值为 1,046,036.55 美元。出售完成后，该执行副总裁直接持有 45,742 股该公司股票，价值 4,366,073.90 美元。这代表了他们持股比例的 19.33% 的减少。该交易在向证券交易委员会提交的文件中披露，可以通过此链接访问。此外，执行副总裁 Delano Ladd 于 12 月 19 日星期五出售了 1,500 股公司的股票。该股票以平均价格 94.72 美元出售，总交易额为 142,080.00 美元。出售后，该执行副总裁持有 73,979 股该公司股票，价值约 7,007,290.88 美元。这代表了他们持股比例的 1.99% 的减少。该销售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了价值 1,640,164 美元的 17,240 股公司股票。当前公司内部人士持有 1.50% 的股票。</p>
<h2>HealthEquity 股价下跌 1.2%</h2>
<ul>
<li>2 适应经济衰退的股票以应对艰难市场环境</li>
</ul>
<p>NASDAQ HQY 周三开盘价为 92.69 美元。该公司的 50 日移动平均价格为 97.21 美元，200 日移动平均价格为 96.05 美元。该公司的债务与股本比率为 0.46，速动比率为 4.13，流动比率为 4.13。HealthEquity, Inc. 的 12 个月低点为 74.07 美元，12 个月高点为 116.65 美元。该股票的市值为 79.2 亿美元，市盈率为 42.52，PEG 比率为 1.36，贝塔值为 0.18。</p>
<p>HealthEquity（NASDAQ:HQY - 获取免费报告）最近于 12 月 3 日星期三发布了其财报。该公司报告本季度每股收益（EPS）为 1.01 美元，超出分析师一致预期的 0.90 美元，超出幅度为 0.11 美元。HealthEquity 的股本回报率为 12.94%，净利润率为 14.86%。该公司在本季度的收入为 3.2216 亿美元，而分析师预期为 3.2092 亿美元。去年同期，该公司每股收益为 0.78 美元。该公司本季度的收入同比增长 7.2%。HealthEquity 已将其 2026 财年指引设定为每股收益 3.870-3.950。股票分析师预计 HealthEquity, Inc. 本年度将发布 2.32 美元的每股收益。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>HealthEquity 股票：领先的健康储蓄账户投资</li>
</ul>
<p>几家研究公司最近对 HQY 发表了评论。Barrington Research 在 12 月 4 日星期四重新发布了 “跑赢大盘” 的评级，并设定了 HealthEquity 股票的目标价为 125.00 美元。巴克莱在 12 月 8 日星期一的研究报告中开始覆盖 HealthEquity。他们设定了 “增持” 评级和 118.00 美元的目标价。华尔街 Zen 在 11 月 15 日星期六的报告中将 HealthEquity 的评级从 “买入” 下调至 “持有”。摩根大通将 HealthEquity 的目标价从 126.00 美元提高至 129.00 美元，并在 12 月 4 日星期四的研究报告中给予该股票 “增持” 评级。最后，BTIG Research 在 12 月 4 日星期四的报告中重申了 “买入” 评级，并设定了 HealthEquity 股票的目标价为 130.00 美元。两家股票研究分析师对该股票给予了强烈买入评级，十二家给予了买入评级，三家对该公司的股票给予了持有评级。根据 MarketBeat.com，该股票目前的共识评级为 “适度买入”，平均目标价为 120.27 美元。</p>
<p><strong>查看我们关于 HealthEquity 的最新报告</strong></p>
<h2>HealthEquity 概况</h2>
<p>（免费报告）</p>
<p>HealthEquity, Inc NASDAQ: HQY 是美国领先的消费者导向健康账户及相关福利解决方案的管理公司。成立于 2002 年，总部位于犹他州德雷珀，该公司专注于健康储蓄账户（HSAs），并提供灵活支出账户（FSAs）、健康报销安排（HRAs）、COBRA 管理和通勤福利等补充服务。通过其技术驱动的平台，HealthEquity 使雇主、健康计划和个人能够简化账户管理，提高成本透明度，并鼓励更明智的医疗支出。</p>
<p>HealthEquity 在所有 50 个州为数百万会员提供服务，利用开放架构生态系统与健康计划、薪资提供商和金融机构进行整合。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票比 HealthEquity 更好</li>
<li>可能每月支付高达 $4,290 的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解析</li>
<li>在 1 月 1 日之前投资 $1,000 到这只股票 [不是 NVDA]</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>特朗普做了什么？？</li>
</ul>
<p><strong>想看看其他对 HQY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 HealthEquity, Inc. (NASDAQ:HQY - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFFZ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFFZ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 到 HealthEquity 吗？</h2>
<p>在考虑投资 HealthEquity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HealthEquity 并不在名单上。</p>
<p>虽然 HealthEquity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>DAVENPORT & Co LLC 在第三季度将其在 HealthEquity, Inc. 的持股增加了 23.9%，目前持有 386,388 股，价值 3677 万美元。其他机构投资者也调整了他们的持股。HealthEquity 的股票开盘价为 92.69 美元，市值为 79.2 亿美元。该公司报告第三季度每股收益为 1.01 美元，超出预期，收入为 3.2216 亿美元，同比增长 7.2%。分析师为该股票设定的目标价为 125.00 美元</p>

<p>DAVENPORT &amp; Co LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 23.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 386,388 shares of the company's stock after acquiring an additional 74,431 shares during the quarter. DAVENPORT &amp; Co LLC owned about 0.45% of HealthEquity worth $36,773,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>DAVENPORT &amp; Co LLC 在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在 HealthEquity, Inc.（NASDAQ:HQY - 免费报告）中的持股比例提高了 23.9%。该公司在季度内额外收购了 74,431 股后，持有该公司 386,388 股股票。DAVENPORT &amp; Co LLC 在最近的报告期末持有约 0.45% 的 HealthEquity，价值 36,773,000 美元。</p>
</div><ul>
<li>Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop</li>
</ul>
<div class="lb-trans"><ul>
<li>选举后罗素 2000 指数飙升：如何把握小盘股的机会</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Price T Rowe Associates Inc. MD boosted its stake in HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock valued at $56,500,000 after buying an additional 580,988 shares in the last quarter. Westfield Capital Management Co. LP lifted its holdings in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company's stock valued at $132,543,000 after acquiring an additional 701,819 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. bought a new position in shares of HealthEquity during the 2nd quarter valued at about $492,000. Artisan Partners Limited Partnership boosted its position in shares of HealthEquity by 44.8% during the 2nd quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company's stock valued at $65,124,000 after purchasing an additional 192,252 shares in the last quarter. Finally, Ashford Capital Management Inc. grew its stake in shares of HealthEquity by 2.1% in the 1st quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company's stock worth $24,302,000 after purchasing an additional 5,687 shares during the last quarter. Institutional investors own 99.55% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也增加或减少了在 HQY 的持股。Price T Rowe Associates Inc. MD 在第一季度将其在 HealthEquity 的持股比例提高了 995.6%。Price T Rowe Associates Inc. MD 目前持有 639,345 股该公司股票，价值 56,500,000 美元，此前在上个季度又购买了 580,988 股。Westfield Capital Management Co. LP 在第二季度将其在 HealthEquity 的持股提高了 124.6%。Westfield Capital Management Co. LP 目前持有 1,265,208 股该公司股票，价值 132,543,000 美元，此前在上个季度又收购了 701,819 股。Banco Bilbao Vizcaya Argentaria S.A. 在第二季度购买了 HealthEquity 的新头寸，价值约 492,000 美元。Artisan Partners Limited Partnership 在第二季度将其在 HealthEquity 的持股提高了 44.8%。Artisan Partners Limited Partnership 目前持有 621,647 股该公司股票，价值 65,124,000 美元，此前在上个季度又购买了 192,252 股。最后，Ashford Capital Management Inc. 在第一季度将其在 HealthEquity 的持股提高了 2.1%。Ashford Capital Management Inc. 目前持有 274,999 股该公司股票，价值 24,302,000 美元，此前在上个季度又购买了 5,687 股。机构投资者目前持有该公司 99.55% 的股票。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company's stock, valued at $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the firm's stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company's stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 17,240 shares of company stock worth $1,640,164. 1.50% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，执行副总裁 Elimelech Rosner 于 12 月 18 日星期四出售了 10,959 股该股票。股票以平均价格 95.45 美元出售，总价值为 1,046,036.55 美元。出售完成后，该执行副总裁直接持有 45,742 股该公司股票，价值 4,366,073.90 美元。这代表了他们持股比例的 19.33% 的减少。该交易在向证券交易委员会提交的文件中披露，可以通过此链接访问。此外，执行副总裁 Delano Ladd 于 12 月 19 日星期五出售了 1,500 股公司的股票。该股票以平均价格 94.72 美元出售，总交易额为 142,080.00 美元。出售后，该执行副总裁持有 73,979 股该公司股票，价值约 7,007,290.88 美元。这代表了他们持股比例的 1.99% 的减少。该销售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了价值 1,640,164 美元的 17,240 股公司股票。当前公司内部人士持有 1.50% 的股票。</p>
</div><h2>HealthEquity Trading Down 1.2%</h2>
<div class="lb-trans"><h2>HealthEquity 股价下跌 1.2%</h2>
</div><ul>
<li>2 Recession-Resistant Stocks for Tough Market Conditions</li>
</ul>
<div class="lb-trans"><ul>
<li>2 适应经济衰退的股票以应对艰难市场环境</li>
</ul>
</div><p>NASDAQ HQY opened at $92.69 on Wednesday. The firm's 50 day moving average price is $97.21 and its two-hundred day moving average price is $96.05. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The stock has a market cap of $7.92 billion, a price-to-earnings ratio of 42.52, a PEG ratio of 1.36 and a beta of 0.18.</p>
<div class="lb-trans"><p>NASDAQ HQY 周三开盘价为 92.69 美元。该公司的 50 日移动平均价格为 97.21 美元，200 日移动平均价格为 96.05 美元。该公司的债务与股本比率为 0.46，速动比率为 4.13，流动比率为 4.13。HealthEquity, Inc. 的 12 个月低点为 74.07 美元，12 个月高点为 116.65 美元。该股票的市值为 79.2 亿美元，市盈率为 42.52，PEG 比率为 1.36，贝塔值为 0.18。</p>
</div><p>HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the company earned $0.78 earnings per share. The company's revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.</p>
<div class="lb-trans"><p>HealthEquity（NASDAQ:HQY - 获取免费报告）最近于 12 月 3 日星期三发布了其财报。该公司报告本季度每股收益（EPS）为 1.01 美元，超出分析师一致预期的 0.90 美元，超出幅度为 0.11 美元。HealthEquity 的股本回报率为 12.94%，净利润率为 14.86%。该公司在本季度的收入为 3.2216 亿美元，而分析师预期为 3.2092 亿美元。去年同期，该公司每股收益为 0.78 美元。该公司本季度的收入同比增长 7.2%。HealthEquity 已将其 2026 财年指引设定为每股收益 3.870-3.950。股票分析师预计 HealthEquity, Inc. 本年度将发布 2.32 美元的每股收益。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>HealthEquity Stock: Leading Health Savings Account Investment</li>
</ul>
<div class="lb-trans"><ul>
<li>HealthEquity 股票：领先的健康储蓄账户投资</li>
</ul>
</div><p>Several research firms recently commented on HQY. Barrington Research reissued an &#34;outperform&#34; rating and set a $125.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Barclays started coverage on HealthEquity in a research report on Monday, December 8th. They set an &#34;overweight&#34; rating and a $118.00 price objective for the company. Wall Street Zen cut HealthEquity from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, November 15th. JPMorgan Chase &amp; Co. boosted their target price on HealthEquity from $126.00 to $129.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, December 4th. Finally, BTIG Research reaffirmed a &#34;buy&#34; rating and set a $130.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $120.27.</p>
<div class="lb-trans"><p>几家研究公司最近对 HQY 发表了评论。Barrington Research 在 12 月 4 日星期四重新发布了 “跑赢大盘” 的评级，并设定了 HealthEquity 股票的目标价为 125.00 美元。巴克莱在 12 月 8 日星期一的研究报告中开始覆盖 HealthEquity。他们设定了 “增持” 评级和 118.00 美元的目标价。华尔街 Zen 在 11 月 15 日星期六的报告中将 HealthEquity 的评级从 “买入” 下调至 “持有”。摩根大通将 HealthEquity 的目标价从 126.00 美元提高至 129.00 美元，并在 12 月 4 日星期四的研究报告中给予该股票 “增持” 评级。最后，BTIG Research 在 12 月 4 日星期四的报告中重申了 “买入” 评级，并设定了 HealthEquity 股票的目标价为 130.00 美元。两家股票研究分析师对该股票给予了强烈买入评级，十二家给予了买入评级，三家对该公司的股票给予了持有评级。根据 MarketBeat.com，该股票目前的共识评级为 “适度买入”，平均目标价为 120.27 美元。</p>
</div><p><strong>Check Out Our Latest Report on HealthEquity</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HealthEquity 的最新报告</strong></p>
</div><h2>HealthEquity Profile</h2>
<div class="lb-trans"><h2>HealthEquity 概况</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.</p>
<div class="lb-trans"><p>HealthEquity, Inc NASDAQ: HQY 是美国领先的消费者导向健康账户及相关福利解决方案的管理公司。成立于 2002 年，总部位于犹他州德雷珀，该公司专注于健康储蓄账户（HSAs），并提供灵活支出账户（FSAs）、健康报销安排（HRAs）、COBRA 管理和通勤福利等补充服务。通过其技术驱动的平台，HealthEquity 使雇主、健康计划和个人能够简化账户管理，提高成本透明度，并鼓励更明智的医疗支出。</p>
</div><p>Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.</p>
<div class="lb-trans"><p>HealthEquity 在所有 50 个州为数百万会员提供服务，利用开放架构生态系统与健康计划、薪资提供商和金融机构进行整合。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than HealthEquity</li>
<li>The boring AI play that could pay up to $4,290 monthly</li>
<li>Trump’s “real estate deal for America” explained</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>ALERT: Drop these 5 stocks before January 2026!</li>
<li>Trump Did WHAT??</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 HealthEquity 更好</li>
<li>可能每月支付高达 $4,290 的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解析</li>
<li>在 1 月 1 日之前投资 $1,000 到这只股票 [不是 NVDA]</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>特朗普做了什么？？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HQY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 HQY 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 HealthEquity, Inc. (NASDAQ:HQY - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SFFZ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=HQY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in HealthEquity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 到 HealthEquity 吗？</h2>
</div><p>Before you consider HealthEquity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 HealthEquity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HealthEquity 并不在名单上。</p>
</div><p>While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HealthEquity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

DAVENPORT & Co LLC 购买了 HealthEquity, Inc. $HQY 的股票